Sucroferric oxyhydroxide use in patients on haemodialysis – real-world experience from an Asian cohort
Background Sucroferric oxyhydroxide has been used in the treatment of hyperphosphataemia in adult patients with chronic kidney disease receiving haemodialysis or peritoneal dialysis since 2013. However, there is a paucity of data on sucroferric oxyhydroxide use in Asian populations. Objective We aim...
Main Authors: | Rachel Zui Chih Teo, Anne Lay Choo Ng, Vincent See, Hua Yan, Tripti Singh, Behram Ali Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-09-01
|
Series: | Proceedings of Singapore Healthcare |
Online Access: | https://doi.org/10.1177/20101058231204709 |
Similar Items
-
Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients
by: Fumihiko Koiwa, et al.
Published: (2018-01-01) -
Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study
by: María Auxiliadora Bajo, et al.
Published: (2022-09-01) -
A 6-Month clinical practice pilot study of sucroferric oxyhydroxide on nutritional status in patients on peritoneal dialysis
by: Luis Perez, et al.
Published: (2022-07-01) -
Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide
by: Gray K, et al.
Published: (2019-01-01) -
Removal Of Arsenic Using Synthetic Iron Oxyhydroxide
by: Mohd Aaznan, Nur Aina Najeehah
Published: (2018)